One of the major challenges in biologic toxicology is their immunogenicity, which refers to the ability of a biologic to elicit an immune response. This can lead to the production of anti-drug antibodies that may neutralize the biologic's effects or cause adverse reactions. Additionally, due to their complexity, biologics often require specialized assays and models to adequately assess their safety and efficacy.
